Proton pump inhibitors are associated with increased risk of alopecia areata: A nationwide nested case-control study - 28/04/20
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Funding sources: The study was supported by grant from Taipei Veterans General Hospital (V106B-020, V107B-010, V107C-181, V108B-012) and the Taiwan Ministry of Science and Technology (107-2314-B-075-063-MY3, 107-2314-B-075-032-MY3-2, 108-2314-B-075-037). The funding sources had no role in any process of our study. None of the aforementioned funding organizations had any role in the study design, data collection, analysis, interpretation of result, writing of the report, and the ultimate decision to submit the paper for publication. |
|
Conflicts of interest: None disclosed. |
|
IRB approval status: The Taipei Veterans General Hospital Institutional Review Board approved this study (2018-07-016AC). |
|
Reprints not available from the authors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?